Global Hereditary Cancer Testing Market Overview:
Global Hereditary Cancer Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Hereditary Cancer Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Hereditary Cancer Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Hereditary Cancer Testing Market:
The Hereditary Cancer Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Hereditary Cancer Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Hereditary Cancer Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Hereditary Cancer Testing market has been segmented into:
Genetic Testing
Carrier Screening
Expanded Panel Testing
Single Gene Testing
By Application, Hereditary Cancer Testing market has been segmented into:
PCR (Polymerase Chain Reaction
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Hereditary Cancer Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Hereditary Cancer Testing market.
Top Key Players Covered in Hereditary Cancer Testing market are:
Myriad Genetics
Color Genomics
Invitae
Ambry Genetics
Illumina
Quest Diagnostics
NeoGenomics
Guardant Health
Dante Labs
Sema4
23andMe
PathGroup
GeneDX
Fulgent Genetics
Laboratory Corporation of America
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Hereditary Cancer Testing Market Type
4.1 Hereditary Cancer Testing Market Snapshot and Growth Engine
4.2 Hereditary Cancer Testing Market Overview
4.3 Genetic Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Genetic Testing: Geographic Segmentation Analysis
4.4 Carrier Screening
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Carrier Screening: Geographic Segmentation Analysis
4.5 Expanded Panel Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Expanded Panel Testing: Geographic Segmentation Analysis
4.6 Single Gene Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Single Gene Testing: Geographic Segmentation Analysis
Chapter 5: Hereditary Cancer Testing Market Application
5.1 Hereditary Cancer Testing Market Snapshot and Growth Engine
5.2 Hereditary Cancer Testing Market Overview
5.3 PCR (Polymerase Chain Reaction
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 PCR (Polymerase Chain Reaction: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Hereditary Cancer Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MYRIAD GENETICS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 COLOR GENOMICS
6.4 INVITAE
6.5 AMBRY GENETICS
6.6 ILLUMINA
6.7 QUEST DIAGNOSTICS
6.8 NEOGENOMICS
6.9 GUARDANT HEALTH
6.10 DANTE LABS
6.11 SEMA4
6.12 23ANDME
6.13 PATHGROUP
6.14 GENEDX
6.15 FULGENT GENETICS
6.16 LABORATORY CORPORATION OF AMERICA
Chapter 7: Global Hereditary Cancer Testing Market By Region
7.1 Overview
7.2. North America Hereditary Cancer Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Genetic Testing
7.2.2.2 Carrier Screening
7.2.2.3 Expanded Panel Testing
7.2.2.4 Single Gene Testing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 PCR (Polymerase Chain Reaction
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Hereditary Cancer Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Genetic Testing
7.3.2.2 Carrier Screening
7.3.2.3 Expanded Panel Testing
7.3.2.4 Single Gene Testing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 PCR (Polymerase Chain Reaction
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Hereditary Cancer Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Genetic Testing
7.4.2.2 Carrier Screening
7.4.2.3 Expanded Panel Testing
7.4.2.4 Single Gene Testing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 PCR (Polymerase Chain Reaction
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Hereditary Cancer Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Genetic Testing
7.5.2.2 Carrier Screening
7.5.2.3 Expanded Panel Testing
7.5.2.4 Single Gene Testing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 PCR (Polymerase Chain Reaction
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Hereditary Cancer Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Genetic Testing
7.6.2.2 Carrier Screening
7.6.2.3 Expanded Panel Testing
7.6.2.4 Single Gene Testing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 PCR (Polymerase Chain Reaction
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Hereditary Cancer Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Genetic Testing
7.7.2.2 Carrier Screening
7.7.2.3 Expanded Panel Testing
7.7.2.4 Single Gene Testing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 PCR (Polymerase Chain Reaction
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Hereditary Cancer Testing Scope:
|
Report Data
|
Hereditary Cancer Testing Market
|
|
Hereditary Cancer Testing Market Size in 2025
|
USD XX million
|
|
Hereditary Cancer Testing CAGR 2025 - 2032
|
XX%
|
|
Hereditary Cancer Testing Base Year
|
2024
|
|
Hereditary Cancer Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Myriad Genetics, Color Genomics, Invitae, Ambry Genetics, Illumina, Quest Diagnostics, NeoGenomics, Guardant Health, Dante Labs, Sema4, 23andMe, PathGroup, GeneDX, Fulgent Genetics, Laboratory Corporation of America.
|
|
Key Segments
|
By Type
Genetic Testing
Carrier Screening
Expanded Panel Testing
Single Gene Testing
By Applications
PCR (Polymerase Chain Reaction
|
